Gene signatures could identify patients with immunogenic tumors with favorable clinical outcomes

A new genetic test could help predict responses to therapy and survival outcomes among cancer patients with tumors that are infiltrated with large numbers of regulatory T cells (Tregs). Read in full.

Browse Articles

Nature events Directory